Mycobacteriophage-antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus
Infection by multidrug-resistant Mycobacterium abscessus is increasingly prevalent in cystic fibrosis (CF) patients, leaving clinicians with few therapeutic options. A compassionate study showed the clinical improvement of a CF patient with a disseminated M. abscessus (GD01) infection, following inj...
Saved in:
Main Authors: | Matt D. Johansen (Author), Matthéo Alcaraz (Author), Rebekah M. Dedrick (Author), Françoise Roquet-Banères (Author), Claire Hamela (Author), Graham F. Hatfull (Author), Laurent Kremer (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aminoglycoside Antibiotics Inhibit Mycobacteriophage Infection
by: Zheng Jiang, et al.
Published: (2020) -
Alternatives to Antibiotics against <i>Mycobacterium abscessus</i>
by: Antonio Broncano-Lavado, et al.
Published: (2022) -
Mycobacteriophages and Their Applications
by: Andrea Bonacorsi, et al.
Published: (2024) -
Cord formation in Mycobacterium abscessus
by: C Adikaram, et al.
Published: (2015) -
Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection.
by: Alexandra G Fraga, et al.
Published: (2019)